100 related articles for article (PubMed ID: 18610743)
21. Efficient inhibition of ovarian cancer growth and prolonged survival by transfection with a novel pro-apoptotic gene, hPNAS-4, in a mouse model. In vivo and in vitro results.
Yang F; Li Z; Deng H; Yang H; Yan F; Qian Z; Chen L; Wei Y; Zhao X
Oncology; 2008; 75(3-4):137-44. PubMed ID: 18824876
[TBL] [Abstract][Full Text] [Related]
22. [Adenovirus mediated angiostatin gene therapy for ovarian cancer: experiment with nude mice].
Jia CR; Yang SY; Han SY; Sun L
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(31):2204-8. PubMed ID: 19080673
[TBL] [Abstract][Full Text] [Related]
23. Purification by affinity chromatography with anti-idiotypic monoclonal antibodies of immunoreactive monoclonal antibodies following labeling with 188Re.
Hamby CV; Chinol M; Manzo C; Ferrone S
Hybridoma; 1997 Feb; 16(1):27-31. PubMed ID: 9085125
[TBL] [Abstract][Full Text] [Related]
24. Localization of colorectal carcinoma by rhenium-188-labeled B72.3 antibody in xenografted mice.
Hosono MN; Hosono M; Zamora PO; Guhlke S; Haberberger T; Bender H; Knapp FF; Biersack HJ
Ann Nucl Med; 1998 Apr; 12(2):83-8. PubMed ID: 9637278
[TBL] [Abstract][Full Text] [Related]
25. Intravesical alpha-radioimmunotherapy with 213Bi-anti-EGFR-mAb defeats human bladder carcinoma in xenografted nude mice.
Pfost B; Seidl C; Autenrieth M; Saur D; Bruchertseifer F; Morgenstern A; Schwaiger M; Senekowitsch-Schmidtke R
J Nucl Med; 2009 Oct; 50(10):1700-8. PubMed ID: 19793735
[TBL] [Abstract][Full Text] [Related]
26. [Metabolism of 125I labeled anti-p185 antibodies in vitro and their biodistribution in vivo].
Wang HY; Liu HB; Dong YQ; Yang JH; Cheng LS; Liu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Sep; 21(5):591-4. PubMed ID: 16143064
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and preliminary biological studies of the novel conjugate 188Re-labeled meso-tetrakis(4-sulfophenyl)porphyrin in mice.
Jia Z; Deng H; Pu M
Nucl Med Biol; 2007 Aug; 34(6):643-9. PubMed ID: 17707804
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis, and evaluation of [188Re]organorhenium-labeled antibody fragments with renal enzyme-cleavable linkage for low renal radioactivity levels.
Uehara T; Koike M; Nakata H; Hanaoka H; Iida Y; Hashimoto K; Akizawa H; Endo K; Arano Y
Bioconjug Chem; 2007; 18(1):190-8. PubMed ID: 17226973
[TBL] [Abstract][Full Text] [Related]
29. Armed antibodies targeting the mucin repeats of the ovarian cancer antigen, MUC16, are highly efficacious in animal tumor models.
Chen Y; Clark S; Wong T; Chen Y; Chen Y; Dennis MS; Luis E; Zhong F; Bheddah S; Koeppen H; Gogineni A; Ross S; Polakis P; Mallet W
Cancer Res; 2007 May; 67(10):4924-32. PubMed ID: 17510422
[TBL] [Abstract][Full Text] [Related]
30. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
31. Clinical aspects of local and regional tumor therapy with 188Re-RC-160.
Bender H; Zamora PO; Rhodes BA; Guhlke S; Biersack HJ
Anticancer Res; 1997; 17(3B):1705-12. PubMed ID: 9179223
[TBL] [Abstract][Full Text] [Related]
32. 188Re-labeled bisphosphonates as potential bifunctional agents for therapy in patients with bone metastases.
El-Mabhouh A; Mercer JR
Appl Radiat Isot; 2005 Apr; 62(4):541-9. PubMed ID: 15701408
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of human prostate cancer xenograft growth by 125I labeled triple-helix forming oligonucleotide directed against androgen receptor.
Zhang Y; Ma Y; Lu HP; Gao JH; Liang CS; Liu CZ; Zou JT; Wang HQ
Chin Med J (Engl); 2008 Nov; 121(22):2284-9. PubMed ID: 19080333
[TBL] [Abstract][Full Text] [Related]
34. [In vitro and in vivo functional evaluation of anti-human bladder tumor human-mouse chimeric antibody ch-BDI].
Bai Y; Yu LZ; Lü YQ; Ai JK; Zhang CL; Ding Y; Wang Y
Zhonghua Wai Ke Za Zhi; 2003 Feb; 41(2):96-8. PubMed ID: 12783667
[TBL] [Abstract][Full Text] [Related]
35. Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model.
You MH; Kim WJ; Shim W; Lee SR; Lee G; Choi S; Kim DY; Kim YM; Kim H; Han SU
J Gastroenterol Hepatol; 2009 Aug; 24(8):1393-400. PubMed ID: 19486256
[TBL] [Abstract][Full Text] [Related]
36. 188Re-labeled anti-epidermal growth factor receptor humanized monoclonal antibody h-R3: labeling conditions, in vitro and in vivo stability.
Iznaga-Escobar N; Ramirez IL; Izquierdo JC; Suárez L; Morales D; Pérez-Rodríguez R
Methods Find Exp Clin Pharmacol; 2003 Nov; 25(9):703-11. PubMed ID: 14685297
[TBL] [Abstract][Full Text] [Related]
37. [Results of 188Re-DTPA-DG-treatment of human breast cancer-bearing nude mice].
Xiong QF; Chen Y; He L
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):589-90. PubMed ID: 18210877
[No Abstract] [Full Text] [Related]
38. A novel mouse monoclonal antibody targeting ErbB2 suppresses breast cancer growth.
Kawa S; Matsushita H; Ohbayashi H; Semba K; Yamamoto T
Biochem Biophys Res Commun; 2009 Jul; 384(3):329-33. PubMed ID: 19409371
[TBL] [Abstract][Full Text] [Related]
39. Adoptive immunotherapy using human peripheral blood lymphocytes transferred with RNA encoding Her-2/neu-specific chimeric immune receptor in ovarian cancer xenograft model.
Yoon SH; Lee JM; Cho HI; Kim EK; Kim HS; Park MY; Kim TG
Cancer Gene Ther; 2009 Jun; 16(6):489-97. PubMed ID: 19096447
[TBL] [Abstract][Full Text] [Related]
40. Imaging of 186Re-liposome therapy in ovarian cancer xenograft model of peritoneal carcinomatosis.
Zavaleta CL; Goins BA; Bao A; McManus LM; McMahan CA; Phillips WT
J Drug Target; 2008 Aug; 16(7):626-37. PubMed ID: 18686134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
